Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating TQF3250 capsules in healthy adult volunteers, with recruitment ongoing for a hyperglycemia indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TQF3250 capsules

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hyperglycemia | Phase 1 | Status: RECRUITING